We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.32%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRE
1276
DELISTED
Duke Realty Corp.
DRE
$5.3M 0.01%
+96,465
New +$5.28M
TRAQ.WS
1277
CALL
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
$5.29M 0.01%
532,456
LMACA
1278
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
$5.29M 0.01%
537,184
IQMD
1279
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
$5.29M 0.01%
527,648
+2,250
+0.4% +$22.5K
GLHAW
1280
CALL
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$5.27M 0.01%
537,491
LUV icon
1281
Southwest Airlines
LUV
$22B
$5.27M 0.01%
145,903
-2,093,744
-93% -$90M
ESAB icon
1282
ESAB
ESAB
$5.43B
$5.26M 0.01%
+120,334
New +$5.81M
CVX icon
1283
Chevron
CVX
$382B
$5.25M 0.01%
36,267
-72,040
-67% -$11.9M
JUN
1284
DELISTED
Juniper II Corp.
JUN
$5.25M 0.01%
528,610
+8,809
+2% +$87.5K
STR
1285
DELISTED
Sitio Royalties
STR
$5.24M 0.01%
226,069
-26,075
-10% -$722K
HHLA.WS
1286
CALL
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$5.24M 0.01%
533,424
NVAC
1287
DELISTED
NorthView Acquisition Corporation Common Stock
NVAC
$5.23M 0.01%
528,451
ROK icon
1288
Rockwell Automation
ROK
$48.6B
$5.23M 0.01%
26,228
-197,286
-88% -$44.6M
OHAA
1289
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
$5.23M 0.01%
531,430
+170,580
+47% +$1.68M
JWSM.WS
1290
CALL
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$5.22M 0.01%
531,512
IBER
1291
DELISTED
Ibere Pharmaceuticals
IBER
$5.22M 0.01%
532,185
KCGI
1292
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$5.21M 0.01%
527,185
TEKKW
1293
CALL
DELISTED
Tekkorp Digital Acquisition Corp. Warrant
TEKKW
$5.21M 0.01%
525,000
CL icon
1294
Colgate-Palmolive
CL
$74.3B
$5.19M 0.01%
64,698
-440,967
-87% -$34.5M
DESP
1295
DELISTED
Despegar.com
DESP
$5.18M 0.01%
639,722
+197,217
+45% +$1.9M
STET.WS
1296
CALL
DELISTED
ST Energy Transition I Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50, included as part of the SAIL securities
STET.WS
$5.18M 0.01%
524,998
+149,998
+40% +$42.7K
IPOD
1297
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$5.17M 0.01%
520,712
WMK icon
1298
Weis Markets
WMK
$1.8B
$5.16M 0.01%
69,160
+37,174
+116% +$2.88M
VRDN icon
1299
Viridian Therapeutics
VRDN
$2.6B
$5.14M 0.01%
444,799
+427,236
+2,433% +$5.74M
NEOG icon
1300
Neogen
NEOG
$2.5B
$5.14M 0.01%
+213,280
New +$5.72M

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.